Efficacy Parameters
Primary Endpoint
- 6-minute walk distance at end of Period 1
Secondary Endpoints
- Time to clinical worsening
- Death
- Hospitalization due to PAH
- Discontinuation due to worsening PAH
- Start of epoprostenol
- Lung transplantation / septostomy